Policy Title |
Policy Number |
Effective Date |
Abaloparatide (Tymlos) (PDF) |
CP.PHAR.345 |
January 1, 2025 |
Abatacept (Orencia) (PDF) |
CP.PHAR.241 |
January 1, 2025 |
Abemaciclib (Verzenio) (PDF) |
CP.PHAR.355 |
January 1, 2025 |
Abiraterone (Zytiga) (PDF) |
CP.PHAR.84 |
January 1, 2025 |
AbobotulinumtoxinA (Dysport) (PDF) |
CP.PHAR.230 |
June 1, 2024 |
Abrocitinib (Cibinqo) (PDF) |
CP.PHAR.578 |
January 1, 2025 |
Acalabrutinib (Calquence) (PDF) |
CP.PHAR.366 |
January 1, 2025 |
Acyclovir Buccal tab (Sitavig) (PDF) |
CP.PMN.210 |
January 1, 2025 |
Adagrasib (Krazati) (PDF) |
CP.PHAR.605 |
January 1, 2025 |
ADAMTS13, recombinant-krhn (Adzynma) (PDF) |
CP.PHAR.635 |
August 1, 2024 |
Adefovir (Hepsera) (PDF) |
CP.PHAR.142 |
January 1, 2025 |
Ado-Trastuzumab Emtansine (Kadcyla) (PDF) |
CP.PHAR.229 |
June 1, 2024 |
Aducanumab-avwa (Aduhelm) (PDF) |
CP.PHAR.468 |
June 1, 2024 |
Afamelanotide (Scenesse) (PDF) |
CP.PHAR.444 |
May 1, 2024 |
Afamitresgene Autoleucel (Tecelra) (PDF) |
CP.PHAR.678 |
January 1, 2025 |
Afatinib (Gilotrif) (PDF) |
CP.PHAR.298 |
January 1, 2025 |
Aflibercept (Eylea, Eylea HD) (PDF) |
CP.PHAR.184 |
November 1, 2024 |
Agalsidase Beta (Fabrazyme) (PDF) |
CP.PHAR.158 |
July 1, 2024 |
Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF) |
CP.PMN.138 |
January 1, 2025 |
Alectinib (Alecensa) (PDF) |
CP.PHAR.369 |
January 1, 2025 |
Alemtuzumab (Lemtrada) (PDF) |
CP.PHAR.243 |
June 1, 2024 |
Alendronate (Binosto, Fosamax plus D) (PDF) |
CP.PMN.88 |
January 1, 2025 |
Alglucosidase Alfa (Lumizyme) (PDF) |
CP.PHAR.160 |
July 1, 2024 |
Allogeneic Cultured Keratinocytes and Dermal Fibroblasts in Murine Collagen-dsat (StrataGraft) (PDF) |
CP.PHAR.562 |
May 1, 2024 |
Allogenic Processed Thymus Tissue-agdc (Rethymic) (PDF) |
CP.PHAR.563 |
May 1, 2024 |
Alpelisib (Piqray) (PDF) |
CP.PHAR.430 |
January 1, 2025 |
Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF) |
CP.PHAR.94 |
May 1, 2024 |
Amantadine ER (Gocovri,Osmolex ER) (PDF) |
CP.PMN.89 |
January 1, 2025 |
Ambrisentan (Letairis®) (PDF) |
CP.PHAR.190 |
January 1, 2025 |
Amifampridine (Firdapse)(PDF) |
CP.PHAR.411 |
January 1, 2025 |
Amikacin (Arikayce)(PDF) |
CP.PHAR.401 |
January 1, 2025 |
Amisulpride (Barhemsys) (PDF) |
CP.PMN.236 |
October 1, 2024 |
Amivantamab-vmjw (Rybrevant) (PDF) |
CP.PHAR.544 |
January 1, 2025 |
Anifrolumab-fnia (Saphnelo) (PDF) |
CP.PHAR.551 |
March 1, 2025 |
Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF) |
CP.PHAR.217 |
May 1, 2024 |
Antithrombin III (ATryn, Thrombate III) (PDF) |
CP.PHAR.564 |
May 1, 2024 |
Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF) |
CP.PHAR.506 |
January 1, 2025 |
Apalutamide (Erleada) (PDF) |
CP.PCH.45 |
January 1, 2025 |
Apomorphine (Apokyn) (PDF) |
CP.PHAR.488 |
January 1, 2025 |
Aprepitant (Emend®) (PDF) |
CP.PMN.19 |
January 1, 2025 |
Aprocitentan (Tryvio) (PDF) |
CP.PHAR.676 |
January 1, 2025 |
Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) (PDF) |
CP.PHAR.290 |
May 1, 2024 |
Aripiprazole ODT (Abilify) (PDF) |
CP.PCH.37 |
January 1, 2025 |
Armodafinil (Nuvigil) (PDF) |
CP.PMN.35 |
January 1, 2025 |
Asciminib (Scemblix) (PDF) |
CP.PHAR.565 |
January 1, 2025 |
Asenapine (Saphris, Secuado) (PDF) |
CP.PMN.15 |
January 1, 2025 |
Asfotase Alfa (Strensiq) (PDF) |
CP.PHAR.328 |
January 1, 2025 |
Aspirin-dipyridamole (Aggrenox) (PDF) |
CP.PMN.20 |
January 1, 2025 |
Atezolizumab (Tecentriq) (PDF) |
CP.PHAR.235 |
January 1, 2025 |
Atidarsagene autotemcel (Lenmeldy) (PDF) |
CP.PHAR.602 |
September 1, 2024 |
Atogepant (Qulipta) (PDF) |
CP.PHAR.566 |
January 1, 2025 |
Avacincaptad pegol (Izervay) (PDF) |
CP.PHAR.641 |
Retire by March 1, 2025 |
Avacincaptad pegol (Izervay) (PDF) |
CP.PHAR.641 |
March 1, 2025 |
Avacopan (Tavneos) (PDF) |
CP.PHAR.515 |
January 1, 2025 |
Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF) |
CP.PHAR.521 |
July 1, 2024 |
Avapritinib (Ayvakit) (PDF) |
CP.PHAR.454 |
January 1, 2025 |
Avatrombopag (Doptelet) (PDF) |
CP.PHAR.130 |
January 1, 2025 |
Avelumab (Bavencio) (PDF) |
CP.PHAR.333 |
May 1, 2024 |
Axatilimab-csfr (Niktimvo) (PDF) |
CP.PHAR.691 |
January 1, 2025 |
Axicabtagene Ciloleucel (Yescarta) (PDF) |
CP.PHAR.362 |
May 1, 2024 |
Axitinib (Inlyta) (PDF) |
CP.PHAR.100 |
January 1, 2025 |
Azacitidine (Onureg, Vidaza) (PDF) |
CP.PHAR.387 |
Retire by March 1, 2025 |
Azacitidine (Onureg, Vidaza) (PDF) |
CP.PHAR.387 |
March 1, 2025 |
Azelaic Acid (Finacea) (PDF) |
HIM.PA.119 |
January 1, 2025 |
Aztreonam (Cayston) (PDF) |
CP.PHAR.209 |
January 1, 2025 |
Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF) |
CP.PHAR.149 |
January 1, 2025 |
Baloxavir Marboxil (Xofluza) (PDF) |
CP.PMN.185 |
January 1, 2025 |
Bedaquiline (Sirturo) (PDF) |
CP.PMN.212 |
January 1, 2025 |
Belantamab Mafodotin-blmf (Blenrep) (PDF) |
CP.PHAR.469 |
June 1, 2024 |
Belatacept (Nulojix) (PDF) |
CP.PHAR.201 |
January 1, 2025 |
Belimumab (Benlysta) (PDF) |
CP.PHAR.88 |
October 1, 2024 |
Belinostat (Beleodaq) (PDF) |
CP.PHAR.311 |
Retire by March 1, 2025 |
Belinostat (Beleodaq) (PDF) |
CP.PHAR.311 |
March 1, 2025 |
Belumosudil (Rezurock) (PDF) |
CP.PHAR.552 |
January 1, 2025 |
Belzutifan (Welireg) (PDF) |
CP.PHAR.553 |
January 1, 2025 |
Bempedoic acid (Nexletol), bempedoic acid-ezetimibe (Nexlizet) (PDF) |
CP.PMN.237 |
January 1, 2025 |
Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (PDF) |
CP.PHAR.307 |
Retire by March 1, 2025 |
Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (PDF) |
CP.PHAR.307 |
March 1, 2025 |
Benralizumab (Fasenra) (PDF) |
HIM.PA.SP70 |
March 1, 2025 |
Benznidazole (PDF) |
CP.PMN.90 |
January 1, 2025 |
Berdazimer (Zelsuvmi) (PDF) |
CP.PMN.293 |
January 1, 2025 |
Beremagene geperpavec-svdt (Vyjuvek) (PDF) |
CP.PHAR.592 |
September 1, 2024 |
Berotralstat (Orladeyo) (PDF) |
HIM.PA.169 |
January 1, 2025 |
Betaine (Cystadane) (PDF) |
CP.PHAR.143 |
January 1, 2025 |
Betamethasone Dipropionate Spray (Sernivo) (PDF) |
CP.PMN.182 |
January 1, 2025 |
Betibeglogene Autotemcel (Zynteglo) (PDF) |
CP.PHAR.545 |
October 1, 2024 |
Bevacizumab (Alymsys, Avastin, Mvasi, Vegzelma, Zirabev) (PDF) |
CP.PHAR.93 |
March 1, 2025 |
Bevacizumab (Alymsys, Avastin, Mvasi, Vegzelma, Zirabev) (PDF) |
CP.PHAR.93 |
Retire by March 1, 2025 |
Bexarotene (Targretin) (PDF) |
CP.PHAR.75 |
January 1, 2025 |
Bezlotoxumab (Zinplava) (PDF) |
CP.PHAR.300 |
May 1, 2024 |
Bimatoprost Implant (Durysta) (PDF) |
CP.PHAR.486 |
June 1, 2024 |
Binimetinib (Mektovi) (PDF) |
CP.PHAR.50 |
January 1, 2025 |
Biologic and Non-biologic DMARDs (PDF) |
HIM.PA.SP60 |
January 1, 2025 |
Birch Triterpenes (Filsuvez) (PDF) |
CP.PHAR.669 |
January 1, 2025 |
Blinatumomab (Blincyto) (PDF) |
CP.PHAR.312 |
November 1, 2024 |
Bortezomib (Velcade) (PDF) |
CP.PHAR.410 |
May 1, 2024 |
Bosentan (Tracleer®) (PDF) |
CP.PHAR.191 |
January 1, 2025 |
Bosutinib (Bosulif) (PDF) |
CP.PHAR.105 |
January 1, 2025 |
Brand Name Override and Non-Formulary Medications (PDF) |
HIM.PA.103 |
January 1, 2025 |
Brentuximab Vedotin (Adcetris) (PDF) |
CP.PHAR.303 |
October 1, 2024 |
Brexanolone (Zulresso) (PDF) |
CP.PHAR.417 |
June 1, 2024 |
Brexpiprazole (Rexulti) (PDF) |
CP.PMN.68 |
January 1, 2025 |
Brexucabtagene Autoleucel (Tecartus) (PDF) |
CP.PHAR.472 |
May 1, 2024 |
Brigatinib (Alunbrig) (PDF) |
CP.PHAR.342 |
January 1, 2025 |
Brimonidine Tartrate (Mirvaso) (PDF) |
CP.PMN.192 |
January 1, 2025 |
Brinzolamide/Brimonidine (Simbrinza) (PDF) |
HIM.PA.15 |
January 1, 2025 |
Brivaracetam (Briviact) (PDF) |
CP.PMN.297 |
January 1, 2025 |
Brolucizumab-dbll (Beovu) (PDF) |
CP.PHAR.445 |
May 1, 2024 |
Budesonide (Eohilia, Uceris) (PDF) |
CP.PMN.294 |
January 1, 2025 |
Budesonide (Tarpeyo) (PDF) |
CP.PHAR.572 |
January 1, 2025 |
Buprenorphine (Subutex) (PDF) |
CP.PMN.82 |
January 1, 2025 |
Buprenorphine Injection (Sublocade, Brixadi) (PDF) |
CP.PHAR.289 |
June 1, 2024 |
Buprenorphine/Naloxone (Bunavail, Cassipa, Suboxone, Zubsolv) (PDF) |
CP.PMN.81 |
January 1, 2025 |
Bupropion/Naltrexone (Contr07e) (PDF) |
CP.PCH.12 |
January 1, 2025 |
Burosumab-twza (Crysvita) (PDF) |
CP.PHAR.11 |
May 1, 2024 |
Butorphanol Nasal Spray (PDF) |
HIM.PA.46 |
January 1, 2025 |
C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF) |
HIM.PA.170 |
September 1, 2024 |
Cabazitaxel (Jevtana) (PDF) |
CP.PHAR.316 |
June 1, 2024 |
Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (PDF) |
CP.PHAR.573 |
October 1, 2024 |
Cabozantinib (Cometriq®, Cabometyx®) (PDF) |
CP.PHAR.111 |
January 1, 2025 |
Calcifediol (Rayaldee) (PDF) |
CP.PMN.76 |
January 1, 2025 |
Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF) |
CP.PMN.181 |
January 1, 2025 |
Canakinumab (Ilaris) (PDF) |
CP.PHAR.246 |
July 1, 2024 |
Cannabidiol (Epidiolex) (PDF) |
CP.PMN.164 |
January 1, 2025 |
Capecitabine (Xeloda) (PDF) |
CP.PHAR.60 |
January 1, 2025 |
Capivasertib (Truqap) (PDF) |
CP.PHAR.663 |
January 1, 2025 |
Caplacizumab-yhdp (Cablivi) (PDF) |
CP.PHAR.416 |
June 1, 2024 |
Capmatinib (Tabrecta) (PDF) |
CP.PHAR.494 |
January 1, 2025 |
CarbidopaLevodopa (Crexont, Rytary,Duopa, Dhivy), FoscarbidopaLevodopa (Vyalev) (PDF) |
CP.PMN.238 |
January 1, 2025 |
Carfilzomib (Kyprolis) (PDF) |
CP.PHAR.309 |
Retire by March 1, 2025 |
Carfilzomib (Kyprolis) (PDF) |
CP.PHAR.309 |
March 1, 2025 |
Carglumic acid (Carbaglu®) (PDF) |
CP.PHAR.206 |
January 1, 2025 |
Cariprazine (Vraylar) (PDF) |
CP.PMN.91 |
January 1, 2025 |
Casimersen (Amondys 45) (PDF) |
CP.PHAR.470 |
May 1, 2024 |
Cemiplimab-rwlc (Libtayo) (PDF) |
CP.PHAR.397 |
January1, 2025 |
Cenegermin-bkbj (Oxervate)(PDF) |
CP.PMN.186 |
January 1, 2025 |
Cenobamate (Xcopri) (PDF) |
CP.PMN.231 |
January 1, 2025 |
Ceritinib (Zykadia) (PDF) |
CP.PHAR.349 |
January 1, 2025 |
Cerliponase alfa (Brineura) (PDF) |
CP.PHAR.338 |
October 1, 2024 |
Cetuximab (Erbitux) (PDF) |
CP.PHAR.317 |
Retire by March 1, 2025 |
Cetuximab (Erbitux) (PDF) |
CP.PHAR.317 |
March 1, 2025 |
Chenodiol (Chenodal) (PDF) |
CP.PMN.239 |
January 1, 2025 |
Chlorambucil (Leukeran) (PDF) |
CP.PHAR.554 |
January 1, 2025 |
Chloramphenicol Sodium Succinate (PDF) |
CP.PHAR.388 |
September 1, 2024 |
Cholic Acid (Cholbam) (PDF) |
CP.PHAR.390 |
January 1, 2025 |
Ciclopirox (Penlac) (PDF) |
CP.PMN.24 |
January 1, 2025 |
Ciltacabtagene Autoleucel (Carvykti) (PDF) |
CP.PHAR.533 |
January 1, 2025 |
Cinacalcet (Sensipar) (PDF) |
CP.PHAR.61 |
January 1, 2025 |
Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF) |
CP.PHAR.567 |
January 1, 2025 |
Ciprofloxacin/Fluocinolone (Otovel) (PDF) |
CP.PMN.249 |
January 1, 2025 |
Ciprofloxacin-Dexamethasone (Ciprodex) (PDF) |
CP.PMN.248 |
January 1, 2025 |
Cladribine (Mavenclad) (PDF) |
CP.PHAR.422 |
January 1, 2025 |
Clascoterone (Winlevi) (PDF) |
CP.PMN.257 |
January 1, 2025 |
Clobazam (Onfi) (PDF) |
CP.PMN.54 |
January 1, 2025 |
CNS Stimulants (PDF) |
CP.PMN.92 |
January 1, 2025 |
Cobimetinib (Cotellic) (PDF) |
CP.PHAR.380 |
January 1, 2025 |
Colchicine (Colcrys, Lodoco) (PDF) |
CP.PMN.123 |
January 1, 2025 |
Colesevelam (Welchol) (PDF) |
CP.PMN.250 |
January 1, 2025 |
Collagenase Clostridium Histolyticum (Xiaflex) (PDF) |
CP.PHAR.82 |
September 1, 2024 |
Colonoscopy Preparation Products (PDF) |
CP.PCH.43 |
January 1, 2025 |
Compounded Medications (PDF) |
CP.PMN.280 |
January 1, 2025 |
Conjugated Estrogens/Bazedoxifene (Duavee) (PDF) |
CP.PMN.258 |
January 1, 2025 |
Copanlisib (Aliqopa) (PDF) |
CP.PHAR.357 |
Retire by March 1, 2025 |
Copanlisib (Aliqopa) (PDF) |
CP.PHAR.357 |
March 1, 2025 |
Corticosteroids for Ophthalmic Injection (Dextenza, Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (PDF) |
CP.PHAR.385 |
November 1, 2024 |
Cosyntropin (Cortrosyn) (PDF) |
CP.PHAR.203 |
May 1, 2024 |
Crisaborole (Eucrisa) (PDF) |
CP.PMN.110 |
January 1, 2025 |
Crizanlizumab-tmca (Adakveo) (PDF) |
CP.PHAR.449 |
May 1, 2024 |
Crizotinib (Xalkori) (PDF) |
CP.PHAR.90 |
January 1, 2025 |
Crovalimab (PiaSky) (PDF) |
CP.PHAR.664 |
January 1, 2025 |
Cyclosporine ophthalmic emulsion (Cequa, Klarity-C, Restasis, Verkazia, Vevye) (PDF) |
CP.PMN.48 |
January 1, 2025 |
Cysteamine ophthalmic (Cystaran) (PDF) |
CP.PMN.130 |
January 1, 2025 |
Cysteamine oral (Cystagon, Procysbi) (PDF) |
CP.PHAR.155 |
January 1, 2025 |
Cytomegalovirus Immune Globulin (Cytogam) (PDF) |
CP.PHAR.277 |
September 1, 2024 |
Dabrafenib (Tafinlar) (PDF) |
CP.PHAR.239 |
January 1, 2025 |
Dacomitinib (Vizimpro) (PDF) |
CP.PHAR.399 |
January 1, 2025 |
Dalfampridine (Ampyra) (PDF) |
CP.PHAR.248 |
January 1, 2025 |
Dalteparin (Fragmin) (PDF) |
CP.PHAR.225 |
January 1, 2025 |
Danicopan (ALXN2040) (PDF) |
CP.PHAR.665 |
January 1, 2025 |
Daprodustat (Jesduvroq) (PDF) |
CP.PHAR.628 |
August 1, 2024 |
Dapsone (Aczone Gel) (PDF) |
CP.PCH.32 |
January 1, 2025 |
Daptomycin (Cubicin, Cubicin RF, Dapzura RT) (PDF) |
CP.PHAR.351 |
September 1, 2024 |
Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (PDF) |
CP.PHAR.310 |
November 1, 2024 |
Darbepoetin alfa (Aranesp) (PDF) |
CP.PHAR.236 |
January 1, 2025 |
Darolutamide (Nubeqa) (PDF) |
CP.PHAR.435 |
January 1, 2025 |
Dasabuvir-Ombitasvir-Paritaprevir-Ritonavir (Viekira Pak) (PDF) |
HIM.PA.SP61 |
January 1, 2025 |
Dasatinib (Sprycel) (PDF) |
CP.PHAR.72 |
January 1, 2025 |
Daunorubicin/Cytarabine (Vyxeos) (PDF) |
CP.PHAR.352 |
January1, 2025 |
DaxibotulinumtoxinA-lanm (Daxxify) (PDF) |
CP.PHAR.651 |
January 1, 2025 |
Decitabine-Cedazuridine (Inqovi) (PDF) |
CP.PHAR.479 |
January 1, 2025 |
Deferasirox (Exjade Jadenu) (PDF) |
CP.PHAR.145 |
January 1, 2025 |
Deferiprone (Ferriprox) (PDF) |
CP.PHAR.147 |
January 1, 2025 |
Deferoxamine (Desferal) (PDF) |
CP.PHAR.146 |
September 1, 2024 |
Deflazacort (Emflaza) (PDF) |
CP.PHAR.331 |
January 1, 2025 |
Degarelix Acetate (Firmagon) (PDF) |
CP.PHAR.170 |
January 1, 2025 |
Delafloxacin (Baxdela) (PDF) |
CP.PMN.115 |
September 1, 2024 |
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF) |
CP.PHAR.593 |
January 1, 2025 |
Delandistrogene Moxeparvovec-rokl (Elevidys) (PDF) |
CP.PHAR.593 |
November 1, 2024 |
Denileukin Diftitox-cxdl (Lymphir) (PDF) |
CP.PHAR.693 |
January 1, 2025 |
Denosumab (Prolia, Xgeva) (PDF) |
CP.PHAR.58 |
November 1, 2024 |
Desmopressin Acetate (DDAVP, Stimate, Noctiva) (PDF) |
CP.PHAR.214 |
January 1, 2025 |
Deutetrabenazine (Austedo) (PDF) |
CP.PCH.42 |
January 1, 2025 |
Dexrazoxane (Totect) (PDF) |
CP.PHAR.418 |
July 1, 2024 |
Dextromethorphan-bupropion (Auvelity) (PDF) |
CP.PMN.284 |
January 1, 2025 |
Diazepam (Libervant, Valtoco) (PDF) |
CP.PMN.216 |
January 1, 2025 |
Dichlorphenamide (Keveyis) (PDF) |
CP.PMN.261 |
January 1, 2025 |
Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF) |
CP.PCH.28 |
January 1, 2025 |
Dimethyl fumarate (Tecfidera), diroximel fumarate, monomethyl fumarate (PDF) |
CP.PHAR.249 |
January 1, 2025 |
Dipeptidyl Peptidase-4 Inhibitors (PDF) |
HIM.PA.58 |
January 1, 2025 |
Dolasetron (Anzemet) (PDF) |
CP.PMN.141 |
January 1, 2025 |
Donanemab-azbt (Kisunla) (PDF) |
CP.PHAR.594 |
Retire by March 1, 2025 |
Donanemab-azbt (Kisunla) (PDF) |
CP.PHAR.594 |
March 1, 2025 |
Dornase alfa (Pulmozyme) (PDF) |
CP.PHAR.212 |
January 1, 2025 |
Dostarlimab-gxly (Jemperli) (PDF) |
CP.PHAR.540 |
November 1, 2024 |
Doxepin (Silenor, Prudoxin, Zonalon) |
HIM.PA.147 |
January 1, 2025 |
Doxycycline (Doryx, Oracea, Acticlate) (PDF) |
CP.PMN.79 |
January 1, 2025 |
Dupilumab (Dupixent) (PDF) |
HIM.PA.SP69 |
March 1, 2025 |
Durvalumab (Imfinzi) (PDF) |
CP.PHAR.339 |
November 1, 2024 |
Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF) |
CP.PMN.128 |
January 1, 2025 |
Duvelisib (Copiktra) (PDF) |
CP.PHAR.400 |
January 1, 2025 |
Ecallantide (Kalbitor) (PDF) |
CP.PHAR.177 |
September 1, 2024 |
Eculizumab (Soliris) (PDF) |
CP.PHAR.97 |
January 1, 2025 |
Edaravone (Radicava, Radicava ORS) (PDF) |
CP.PHAR.343 |
June 1, 2024 |
Efgartigimod Alfa-fcab, Efgartigimod/-Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (PDF) |
CP.PHAR.555 |
January1, 2025 |
Efinaconazole (Jublia) (PDF) |
CP.PMN.25 |
January 1, 2025 |
Eflornithine (Iwilfin) (PDF) |
CP.PHAR.670 |
January 1, 2025 |
Elacestrant (Orserdu) (PDF) |
CP.PHAR.623 |
January 1, 2025 |
Elafibranor (Iqirvo) (PDF) |
CP.PHAR.688 |
January 1, 2025 |
Elagolix (Orilissa), elagolix-estradiol-norethindrone (Oriahnn) (PDF) |
CP.PHAR.136 |
January 1, 2025 |
Elapegademase-lvlr (Revcovi) (PDF) |
CP.PHAR.419 |
June 1, 2024 |
Elbasvir/Grazoprevir (Zepatier) (PDF) |
HIM.PA.SP62 |
January 1, 2025 |
Elexacaftor-ivacaftor-tezacaftor (Trikafta) (PDF) |
CP.PHAR.440 |
January 1, 2025 |
Eliglustat (Cerdelga) (PDF) |
CP.PHAR.153 |
January 1, 2025 |
Elivaldogene Autotemcel (Skysona) (PDF) |
CP.PHAR.556 |
January 1, 2025 |
Elosulfase Alfa (Vimizim) (PDF) |
CP.PHAR.162 |
June 1, 2024 |
Elotuzumab (Empliciti) (PDF) |
CP.PHAR.308 |
Retire by March 1, 2025 |
Elotuzumab (Empliciti) (PDF) |
CP.PHAR.308 |
March 1, 2025 |
Elranatamab-bcmm (Elrexfio) (PDF) |
CP.PHAR.652 |
January 1, 2025 |
Eltrombopag (Promacta®) (PDF) |
CP.PHAR.180 |
January 1, 2025 |
Eluxadoline (Viberzi) (PDF) |
CP.PMN.170 |
January 1, 2025 |
Emapalumab-lzsg (Gamifant) (PDF) |
CP.PHAR.402 |
May 1, 2024 |
Emicizumab-kxwh (Hemlibra) (PDF) |
CP.PHAR.370 |
January 1, 2025 |
Emtricitabine-tenofovir alafenamide (Descovy) (PDF) |
CP.PMN.235 |
January 1, 2025 |
Enasidenib (Idhifa) (PDF) |
CP.PHAR.363 |
January 1, 2025 |
Encorafenib (Braftovi) (PDF) |
CP.PHAR.127 |
January 1, 2025 |
Enfortumab Vedotin-ejfv (Padcev) (PDF) |
CP.PHAR.455 |
May 1, 2024 |
Enfuvirtide (Fuzeon) (PDF) |
CP.PHAR.41 |
August 1, 2024 |
Enoxaparin (Lovenox) (PDF) |
CP.PHAR.224 |
January 1, 2025 |
Entecavir (Baraclude) (PDF) |
HIM.PA.08 |
January 1, 2025 |
Entrectinib (Rozlytrek) (PDF) |
CP.PHAR.441 |
January 1, 2025 |
Enzalutamide (Xtandi) (PDF) |
CP.PHAR.106 |
January 1, 2025 |
Epcoritamab-bysp (Epkinly) (PDF) |
CP.PHAR.634 |
September 1, 2024 |
Eplontersen (Wainua) |
CP.PHAR.633 |
January 1, 2025 |
Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF) |
CP.PHAR.237 |
August 1, 2024 |
Epoprostenol (Flolan, Veletri) (PDF) |
CP.PHAR.192 |
May 1, 2024 |
Eptinezumab-jjmr (Vyepti) (PDF) |
HIM.PA.SP64 |
Retire by March 1, 2025 |
Eptinezumab-jjmr (Vyepti) (PDF) |
HIM.PA.SP64 |
March 1, 2025 |
Erdafitinib (Balversa) (PDF) |
CP.PHAR.423 |
January 1, 2025 |
Erenumab-aaoe (Aimovig) (PDF) |
HIM.PA.SP65 |
January 1, 2025 |
Eribulin Mesylate (Halaven) (PDF) |
CP.PHAR.318 |
January 1, 2025 |
Erlotinib (Tarceva) (PDF) |
CP.PHAR.74 |
January 1, 2025 |
Erwinia Asparaginase (Erwinaze, Rylaze) (PDF) |
CP.PHAR.301 |
May 1, 2024 |
Esketamine (Spravato) (PDF) |
CP.PMN.199 |
May 1, 2024 |
Estradiol Vaginal Ring (Femring) (PDF) |
CP.PMN.263 |
January 1, 2025 |
Etelcalcetide (Parsabiv) (PDF) |
CP.PHAR.379 |
September 1, 2024 |
Eteplirsen (Exondys 51) (PDF) |
CP.PHAR.288 |
May 1, 2024 |
Etranacogene Dezaparvovec-drlb (Hemgenix) (PDF) |
CP.PHAR.580 |
Retire by March 1, 2025 |
Etranacogene Dezaparvovec-drlb (Hemgenix) (PDF) |
CP.PHAR.580 |
March 1, 2025 |
Everolimus (Afinitor, Afinitor Disperz, Zortress)(PDF) |
CP.PHAR.63 |
January 1, 2025 |
Evinacumab-dgnb (Evkeeza) (PDF) |
HIM.PA.166 |
May 1, 2024 |
Evolocumab (Repatha) (PDF) |
HIM.PA.156 |
January 1, 2025 |
Exagamglogene autotemcel (Casgevy) (PDF) |
CP.PHAR.603 |
January 1, 2025 |
Factor IX (Human, Recombinant) (PDF) |
CP.PHAR.218 |
June 1, 2024 |
Factor IX Complex, Human (Profilnine) (PDF) |
CP.PHAR.219 |
June 1, 2024 |
Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF) |
CP.PHAR.220 |
September 1, 2024 |
Factor VIII (Human, Recombinant) (PDF) |
CP.PHAR.215 |
June 1, 2024 |
Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF) |
CP.PHAR.216 |
June 1, 2024 |
Factor XIII A-Subunit, Recombinant (Tretten) (PDF) |
CP.PHAR.222 |
May 1, 2024 |
Factor XIII, Human (Corifact) (PDF) |
CP.PHAR.221 |
May 1, 2024 |
Famotidine-Ibuprofen (Duexis) (PDF) |
CP.PMN.120 |
January 1, 2025 |
Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (PDF) |
CP.PHAR.456 |
August 1, 2024 |
Faricimab-svoa (Vabysmo) (PDF) |
CP.PHAR.581 |
October 1, 2024 |
Febuxostat (Uloric) (PDF) |
CP.PMN.57 |
January 1, 2025 |
Fecal microbiota spores, live-brpk (Vowst) (PDF) |
CP.PHAR.632 |
January 1, 2025 |
Fecal microbiota, live-jslm (Rebyota) (PDF) |
CP.PHAR.613 |
January 1, 2025 |
Fedratinib (Inrebic) (PDF) |
CP.PHAR.442 |
January 1, 2025 |
Fenfluramine (Fintepla) (PDF) |
CP.PMN.246 |
January 1, 2025 |
Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF) |
CP.PMN.127 |
January 1, 2025 |
Ferric Carboxymaltose (Injectafer) (PDF) |
CP.PHAR.234 |
September 1, 2024 |
Ferric Derisomaltose (Monoferric) (PDF) |
CP.PHAR.480 |
November 1, 2024 |
Ferric Maltol (Accrufer) (PDF) |
CP.PMN.213 |
January 1, 2025 |
Ferric Pyrophosphate (Triferic, Triferic Avnu ) (PDF) |
CP.PHAR.624 |
June 1, 2024 |
Ferumoxytol (Feraheme) (PDF) |
CP.PHAR.165 |
September 1, 2024 |
Fezolinetant (Veozah) (PDF) |
CP.PMN.289 |
March 1, 2025 |
Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (PDF) |
CP.PHAR.526 |
November 1, 2024 |
Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF) |
CP.PHAR.643 |
January1, 2025 |
Filgrastim (Neupogen, Zarxio, Granix, Nivestym, Releuko, Nypozi) (PDF) |
CP.PHAR.297 |
January 1, 2025 |
Finerenone (Kerendia) (PDF) |
CP.PMN.266 |
January 1, 2025 |
Fingolimod (Gilenya) (PDF) |
CP.PCH.38 |
January 1, 2025 |
Flibanserin (Addyi) (PDF) |
CP.PHAR.446 |
January 1, 2025 |
Fluorouracil Cream (Tolak) (PDF) |
CP.PMN.165 |
January 1, 2025 |
Fluticasone Propionate (Xhance) (PDF) |
CP.PMN.95 |
January 1, 2025 |
Fondaparinux (Arixtra) (PDF) |
CP.PHAR.226 |
January 1, 2025 |
Fosdenopterin (Nulibry) (PDF) |
CP.PHAR.471 |
June 1, 2024 |
Fostamatinib (Tavalisse) (PDF) |
CP.PHAR.24 |
January 1, 2025 |
Fostemsavir (Rukobia) (PDF) |
CP.PHAR.516 |
January 1, 2025 |
Fremanezumab-vfrm (Ajovy)(PDF) |
HIM.PA.SP66 |
January 1, 2025 |
Fruquintinib (Fruzaqla) (PDF) |
CP.PHAR.666 |
January 1, 2025 |
Fulvestrant (Faslodex Injection) (PDF) |
CP.PHAR.424 |
October 1, 2024 |
Furosemide (Furoscix) (PDF) |
CP.PHAR.608 |
January 1, 2025 |
Futibatinib (Lytgobi) (PDF) |
CP.PHAR.604 |
January 1, 2025 |
Gabapentin ER (Gralise, Horizant) (PDF) |
CP.PMN.240 |
January 1, 2025 |
Galcanezumab-gnlm (Emgality) (PDF) |
HIM.PA.SP67 |
January 1, 2025 |
Galsulfase (Naglazyme) (PDF) |
CP.PHAR.161 |
June 1, 2024 |
Ganaxolone (Ztalmy) (PDF) |
CP.PMN.278 |
January 1, 2025 |
Gefitinib (Iressa) (PDF) |
CP.PHAR.68 |
January 1, 2025 |
Gemtuzumab Ozogamicin (Mylotarg) (PDF) |
CP.PHAR.358 |
January1, 2025 |
Gilteritinib (Xospata) (PDF) |
CP.PHAR.412 |
January 1, 2025 |
Givinostat (Duvyzat) (PDF) |
CP.PHAR.644 |
January 1, 2025 |
Givosiran (Givlaari) (PDF) |
CP.PHAR.457 |
May 1, 2024 |
Glasdegib (Daurismo)(PDF) |
CP.PHAR.413 |
January 1, 2025 |
Glatiramer (Copaxone, Glatopa) (PDF) |
CP.PHAR.252 |
January 1, 2025 |
Glaucoma Agents (Omlonti, Rhopressa, Rocklatan, Vyzulta) (PDF) |
CP.PMN.286 |
January 1, 2025 |
Glecaprevir/Pibrentasvir (Mavyret)(PDF) |
HIM.PA.SP36 |
January 1, 2025 |
Glofitamab-gxbm (Columvi) (PDF) |
CP.PHAR.636 |
September 1, 2024 |
GLP-1 Receptor Agonists (PDF) |
AR.QC.PA.53 |
January 1, 2025 |
Glycerol Phenylbutyrate (Ravicti) (PDF) |
CP.PHAR.207 |
March 1, 2025 |
Golodirsen (Vyondys 53) (PDF) |
CP.PHAR.453 |
May 1, 2024 |
Goserelin Acetate (Zoladex) (PDF) |
CP.PHAR.171 |
January 1, 2025 |
Granisetron (Sancuso, Sustol) (PDF) |
CP.PMN.74 |
January 1, 2025 |
Halcinonide (Halog) (PDF) |
HIM.PA.20 |
January 1, 2025 |
Halobetasol Propionate Lotion (Bryhali, Lexette, Ultravate) (PDF) |
CP.PMN.180 |
January 1, 2025 |
Halobetasol Propionate/Tazarotene (Duobrii) (PDF) |
CP.PMN.208 |
January 1, 2025 |
Hemin (Panhematin) (PDF) |
CP.PHAR.181 |
May 1, 2024 |
Histrelin Acetate (Vantas, Supprelin LA) (PDF) |
CP.PHAR.172 |
July 1, 2024 |
House dust mite allergen extract (Odactra®) (PDF) |
CP.PMN.111 |
January 1, 2025 |
Human Growth Hormone (Somapacitan, Somatropin) (PDF) |
HIM.PA.161 |
January 1, 2025 |
Hyaluronate derivatives (PDF) |
CP.PHAR.05 |
January 1, 2025 |
Hydroxyprogesterone Caproate (Makena) (PDF) |
CP.PHAR.14 |
January 1, 2025 |
Hydroxyurea (Siklos) (PDF) |
CP.PMN.193 |
January 1, 2025 |
Ibalizumab-uiyk (Trogarzo) (PDF) |
CP.PHAR.378 |
August 1, 2024 |
Ibandronate Injection (Boniva) (PDF) |
CP.PHAR.189 |
May 1, 2024 |
Ibrutinib (Imbruvica) (PDF) |
CP.PHAR.126 |
January 1, 2025 |
Icatibant (Firazyr®) (PDF) |
CP.PHAR.178 |
January 1, 2025 |
Icosapent ethyl (Vascepa) (PDF) |
CP.PMN.187 |
January 1, 2025 |
Idecabtagene Vicleucel (Abecma) (PDF) |
CP.PHAR.481 |
January 1, 2025 |
Idelalisib (Zydelig) (PDF) |
CP.PHAR.133 |
January 1, 2025 |
Idursulfase (Elaprase) (PDF) |
CP.PHAR.156 |
June 1, 2024 |
Iloperidone (Fanapt) (PDF) |
CP.PMN.32 |
January 1, 2025 |
Iloprost (Ventavis®) (PDF) |
CP.PHAR.193 |
January 1, 2025 |
Imatinib (Gleevec, Imkeldi) (PDF) |
CP.PHAR.65 |
January 1, 2025 |
Imetelstat (Rytelo) (PDF) |
CP.PHAR.690 |
January 1, 2025 |
Imiglucerase (Cerezyme) (PDF) |
CP.PHAR.154 |
June 1, 2024 |
Immune Globulins (PDF) |
CP.PHAR.103 |
January 1, 2025 |
Inavolisib (Itovebi) (PDF) |
CP.PHAR.702 |
January 1, 2025 |
Inclisiran (Leqvio) (PDF) |
CP.PHAR.568 |
May 1, 2024 |
IncobotulinumtoxinA (Xeomin) (PDF) |
CP.PHAR.231 |
October 1, 2024 |
Inebilizumab-cdon (Uplizna) (PDF) |
CP.PHAR.458 |
January 1, 2025 |
Inebilizumab-cdon (Uplizna) (PDF) |
CP.PHAR.458 |
October 1, 2024 |
Infertility and Fertility Preservation (PDF) |
CP.PHAR.131 |
January 1, 2025 |
Inhaled asthma and COPD agents (PDF) |
HIM.PA.153 |
January 1, 2025 |
Inotersen (Tegsedi) (PDF) |
CP.PHAR.405 |
January 1, 2025 |
Inotuzumab Ozogamicin (Besponsa) (PDF) |
CP.PHAR.359 |
January1, 2025 |
Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF) |
CP.PHAR.534 |
January 1, 2025 |
Insulin Detemir (Levemir) (PDF) |
HIM.PA.171 |
January 1, 2025 |
Insulin Glargine (Basaglar, Rezvoglar, Toujeo, unbranded Semglee) (PDF) |
HIM.PA.09 |
January 1, 2025 |
Interferon Beta-1a (Avonex, Rebif) (PDF) |
CP.PHAR.255 |
January 1, 2025 |
Interferon beta-1b (Betaseron, Extavia) (PDF) |
CP.PCH.46 |
January 1, 2025 |
Interferon Gamma- 1b (Actimmune) (PDF) |
CP.PHAR.52 |
May 1, 2024 |
Iobenguane I-131 (Azedra) (PDF) |
CP.PHAR.459 |
May 1, 2024 |
Ipilimumab (Yervoy) (PDF) |
CP.PHAR.319 |
June 1, 2024 |
Iptacopan (Fabhalta) (PDF) |
CP.PHAR.656 |
January 1, 2025 |
Irinotecan Liposome (Onivyde) (PDF) |
CP.PHAR.304 |
January1, 2025 |
Isatuximab-irfc (Sarclisa) (PDF) |
CP.PHAR.482 |
January 1, 2025 |
Isavuconazonium (Cresemba) (PDF) |
CP.PMN.154 |
June 1, 2024 |
Isotretinoin (Claravis Absorica Absorica LD Myorisan Zenatane Amnesteem) (PDF) |
CP.PMN.143 |
March 1, 2025 |
Istradefylline (Nourianz) (PDF) |
CP.PMN.217 |
January 1, 2025 |
Itraconazole (Sporanox, Onmel) (PDF) |
CP.PMN.124 |
January 1, 2025 |
Ivabradine (Corlanor) (PDF) |
CP.PMN.70 |
January 1, 2025 |
Ivacaftor (Kalydeco) (PDF) |
CP.PHAR.210 |
January 1, 2025 |
Ivermectin (Stromectol, Sklice) (PDF) |
CP.PMN.269 |
January 1, 2025 |
Ivosidenib (Tibsovo) (PDF) |
CP.PHAR.137 |
January 1, 2025 |
Ixazomib (Ninlaro) (PDF) |
CP.PHAR.302 |
January 1, 2025 |
Ketamine (Ketalar) (PDF) |
CP.PMN.296 |
September 1, 2024 |
Ketorolac nasal spray (Sprix) (PDF) |
CP.PMN.282 |
January 1, 2025 |
Lanadelumab-fylo (Takhzyro) (PDF) |
HIM.PA.172 |
May 1, 2024 |
Lanreotide (Somatuline Depot and Unbranded) (PDF) |
CP.PHAR.391 |
January1, 2025 |
Lapatinib (Tykerb®) (PDF) |
CP.PHAR.79 |
January 1, 2025 |
Laronidase (Aldurazyme) (PDF) |
CP.PHAR.152 |
June 1, 2024 |
Larotrectinib (Vitrakvi)(PDF) |
CP.PHAR.414 |
January 1, 2025 |
Lasmiditan (Reyvow) (PDF) |
CP.PMN.218 |
January 1, 2025 |
Lazertinib (Lazcluze) (PDF) |
CP.PHAR.695 |
January 1, 2025 |
Lebrikizumab (Ebglyss) (PDF) |
CP.PHAR.704 |
January 1, 2025 |
Lecanemab-irmb (Leqembi) (PDF) |
CP.PHAR.596 |
Retire by March 1, 2025 |
Lecanemab-irmb (Leqembi) (PDF) |
CP.PHAR.596 |
March 1, 2025 |
Ledipasvir-Sofosbuvir (Harvoni) (PDF) |
HIM.PA.SP3 |
January 1, 2025 |
Lefamulin (Xenleta) (PDF) |
CP.PMN.219 |
September 1, 2024 |
Lenacapavir (Sunlenca) (PDF) |
CP.PHAR.622 |
May 1, 2024 |
Lenalidomide (Revlimid) (PDF) |
CP.PHAR.71 |
January 1, 2025 |
Leniolisib (Joenja) (PDF) |
CP.PHAR.597 |
January 1, 2025 |
Lenvatinib (Lenvima) (PDF) |
CP.PHAR.138 |
January 1, 2025 |
Letermovir (Prevymis) (PDF) |
CP.PHAR.367 |
January 1, 2025 |
Leucovorin Injection (PDF) |
CP.PHAR.393 |
May 1, 2024 |
Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF) |
CP.PHAR.173 |
May 1, 2024 |
Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF) |
CP.PCH.53 |
January 1, 2025 |
Levodopa Inhalation Powder (Inbrija) (PDF) |
CP.PMN.267 |
January 1, 2025 |
Levoketoconazole (Recorlev) (PDF) |
CP.PMN.275 |
January 1, 2025 |
Levoleucovorin (Fusilev, Khapzory) (PDF) |
CP.PHAR.151 |
January 1, 2025 |
Levomilnacipran (Fetzima) (PDF) |
HIM.PA.125 |
January 1, 2025 |
L-glutamine (Endari) (PDF) |
CP.PMN.116 |
January 1, 2025 |
Lifileucel (Amtagvi) (PDF) |
CP.PHAR.598 |
January 1, 2025 |
Lifitegrast (Xiidra®) (PDF) |
CP.PMN.73 |
January 1, 2025 |
Linezolid (Zyvox) (PDF) |
CP.PMN.27 |
August 1, 2024 |
Lisocabtagene Maraleucel (Breyanzi) (PDF) |
CP.PHAR.483 |
August 1, 2024 |
Lofexidine (Lucemyra) (PDF) |
CP.PMN.152 |
January 1, 2025 |
Lomustine (Gleostine) (PDF) |
CP.PHAR.507 |
January 1, 2025 |
Lonafarnib (Zokinvy) (PDF) |
CP.PHAR.499 |
January 1, 2025 |
Loncastuximab Tesirine-lpyl (Zynlonta) (PDF) |
CP.PHAR.539 |
September 1, 2024 |
Lorlatinib (Lorbrena)(PDF) |
CP.PHAR.406 |
January 1, 2025 |
Loteprednol etabonate (Eysuvis) (PDF) |
CP.PMN.260 |
January 1, 2025 |
Lotilaner (Xdemvy) (PDF) |
CP.PMN.291 |
January 1, 2025 |
Lovotibeglogene Autotemcel (Lyfgenia) (PDF) |
CP.PHAR.627 |
August 1, 2024 |
Lubiprostone (Amitiza) (PDF) |
CP.PMN.142 |
January 1, 2025 |
Luliconazole Cream (Luzu) (PDF) |
CP.PMN.166 |
January 1, 2025 |
Lumacaftor-Ivacaftor (Orkambi) (PDF) |
CP.PHAR.213 |
January 1, 2025 |
Lumasiran (Oxlumo) (PDF) |
CP.PHAR.473 |
August 1, 2024 |
Lumateperone (Caplyta) (PDF) |
CP.PMN.232 |
January 1, 2025 |
Lurbinectedin (Zepzelca) (PDF) |
CP.PHAR.500 |
September 1, 2024 |
Luspatercept-aamt (Reblozyl) (PDF) |
CP.PHAR.450 |
December 1, 2024 |
Lusutrombopag (Mulpleta)(PDF) |
CP.PHAR.407 |
January 1, 2025 |
Lutetium Lu 177 dotatate (Lutathera) (PDF) |
CP.PHAR.384 |
September 1, 2024 |
Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (PDF) |
CP.PHAR.582 |
June 1, 2024 |
Macitentan (Opsumit) (PDF) |
CP.PHAR.194 |
January 1, 2025 |
Mannitol (Bronchitol) (PDF) |
CP.PHAR.518 |
January 1, 2025 |
Maralixibat (Livmarli) (PDF) |
CP.PHAR.543 |
January 1, 2025 |
Margetuximab-cmkb (Margenza) (PDF) |
CP.PHAR.522 |
May 1, 2024 |
Maribavir (Livtencity) (PDF) |
CP.PMN.271 |
January 1, 2025 |
Mavacamten (Camzyos) (PDF) |
CP.PMN.272 |
January 1, 2025 |
Mavorixafor (Xolremdi) |
CP.PHAR.679 |
January 1, 2025 |
Mecamylamine (Vecamyl) (PDF) |
CP.PMN.136 |
January 1, 2025 |
Mecasermin (Increlex) (PDF) |
CP.PHAR.150 |
October 1, 2024 |
Megestrol Acetate (PDF) |
CP.PMN.179 |
January 1, 2025 |
Melphalan (Hepzato) (PDF) |
CP.PHAR.653 |
January 1, 2025 |
Melphalan flufenamide (Pepaxto) (PDF) |
CP.PHAR.535 |
June 1, 2024 |
Memantine (Namenda XR, Namzaric) (PDF) |
CP.PCH.30 |
January 1, 2025 |
Mepolizumab (Nucala) (PDF) |
CP.PHAR.200 |
January 1, 2025 |
Mercaptopurine (Purixan) (PDF) |
CP.PHAR.447 |
January 1, 2025 |
Metformin ER (Glumetza, Fortamet) (PDF) |
CP.PMN.72 |
January 1, 2025 |
Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo) (PDF) |
CP.PHAR.134 |
January 1, 2025 |
Methoxsalen (Uvadex) (PDF) |
HIM.PA.17 |
January 1, 2025 |
Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF) |
CP.PHAR.238 |
January 1, 2025 |
Methylnaltrexone Bromide (Relistor) (PDF) |
CP.PMN.169 |
January 1, 2025 |
Metoclopramide (Gimoti) (PDF) |
CP.PMN.252 |
January 1, 2025 |
Metreleptin (Myalept) (PDF) |
CP.PHAR.425 |
September 1, 2024 |
Midazolam (Nayzilam) (PDF) |
CP.PMN.211 |
January 1, 2025 |
Midostaurin (Rydapt) (PDF) |
CP.PHAR.344 |
January 1, 2025 |
Mifepristone (Korlym) (PDF) |
CP.PHAR.101 |
January 1, 2025 |
Migalastat (Galafold) (PDF) |
CP.PHAR.394 |
January 1, 2025 |
Miglustat (Zavesca) (PDF) |
CP.PHAR.164 |
January 1, 2025 |
Milnacipran (Savella) (PDF) |
CP.PMN.125 |
January 1, 2025 |
Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF) |
CP.PMN.80 |
January 1, 2025 |
Mirvetuximab soravatansine-gynx (Elahere) (PDF) |
CP.PHAR.617 |
July 1, 2024 |
Mitapivat (Pyrukynd) (PDF) |
CP.PHAR.558 |
January 1, 2025 |
Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF) |
CP.PHAR.495 |
September 1, 2024 |
Mitoxantrone (PDF) |
CP.PHAR.258 |
July 1, 2024 |
Mixed pollens allergen extract (Oralair) (PDF) |
CP.PMN.85 |
January 1, 2025 |
Mobocertinib (Exkivity) (PDF) |
CP.PHAR.559 |
January 1, 2025 |
Modafinil (Provigil) (PDF) |
CP.PMN.39 |
January 1, 2025 |
Mogamulizumab-kpkc (Poteligeo) (PDF) |
CP.PHAR.139 |
March 1, 2025 |
Mogamulizumab-kpkc (Poteligeo) (PDF) |
CP.PHAR.139 |
Retire by March 1, 2025 |
Momelotinib (Ojjaara) (PDF) |
CP.PHAR.654 |
January 1, 2025 |
Mometasone (Nasonex) (PDF) |
HIM.PA.93 |
January 1, 2025 |
Mometasone Furoate (Sinuva) (PDF) |
CP.PHAR.448 |
August 1, 2024 |
Mosunetuzumab-axgb (Lunsumio) (PDF) |
CP.PHAR.618 |
May 1, 2024 |
Motixafortide (Aphexda) (PDF) |
CP.PHAR.655 |
January 1, 2025 |
Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF) |
CP.PHAR.398 |
January 1, 2025 |
Nabumatone Double-Strength (Relafen DS) (PDF) |
CP.PMN.287 |
January 1, 2025 |
Nadofaragene Firadenovec-vncg (Adstiladrin) (PDF) |
CP.PHAR.461 |
Retire by March 1, 2025 |
Nadofaragene Firadenovec-vncg (Adstiladrin) (PDF) |
CP.PHAR.461 |
March 1, 2025 |
Nafarelin acetate (Synarel®) (PDF) |
CP.PHAR.174 |
January 1, 2025 |
Naldemedine (Symproic) (PDF) |
CP.PMN.112 |
January 1, 2025 |
Nalmefene (Opvee, Zurnai) (PDF) |
CP.PHAR.638 |
January 1, 2025 |
Naloxegol (Movantik) (PDF) |
HIM.PA.167 |
January 1, 2025 |
Naproxen oral suspension (Naprosyn) (PDF) |
HIM.PA.130 |
January 1, 2025 |
Natalizumab (Tysabri) (PDF) |
CP.PHAR.259 |
September 1, 2024 |
Naxitamab-gqgk (Danyelza) (PDF) |
CP.PHAR.523 |
May 1, 2024 |
Necitumumab (Portrazza) (PDF) |
CP.PHAR.320 |
January 1, 2025 |
Nedosiran (Rivfloza) (PDF) |
CP.PHAR.619 |
August 1, 2024 |
Nemolizumab-ito (Nemluvio) (PDF) |
CP.PHAR.703 |
January 1, 2025 |
Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF) |
CP.PMN.167 |
January 1, 2025 |
Neratinib (Nerlynx) (PDF) |
CP.PHAR.365 |
January 1, 2025 |
Netupitant and Palonosetron (Akynzeo) (PDF) |
CP.PMN.158 |
January 1, 2025 |
Nifurtimox (Lampit) (PDF) |
CP.PMN.256 |
January 1, 2025 |
Nilotinib (Tasigna, Danziten) (PDF) |
CP.PHAR.76 |
March 1, 2025 |
Nintedanib (Ofev) (PDF) |
CP.PHAR.285 |
January 1, 2025 |
Niraparib (Zejula) (PDF) |
CP.PHAR.408 |
January 1, 2025 |
Niraparib and Abiraterone (Akeega) (PDF) |
CP.PHAR.645 |
January 1, 2025 |
Nirmatrelvir-Ritonavir (Paxlovid) (PDF) |
CP.PMN.288 |
January 1, 2025 |
Nirogacestat (Ogsiveo) (PDF) |
CP.PHAR.671 |
January 1, 2025 |
Nirsevimab-alip (Beyfortus) (PDF) |
CP.PHAR.614 |
September 1, 2024 |
Nitazoxanide (Alinia) (PDF) |
HIM.PA.152 |
January 1, 2025 |
Nitisinone (Nityr, Orfadin) (PDF) |
CP.PHAR.132 |
January 1, 2025 |
Nivolumab (Opdivo) (PDF) |
CP.PHAR.121 |
Retire by March 1, 2025 |
Nivolumab (Opdivo) (PDF) |
CP.PHAR.121 |
March 1, 2025 |
Nivolumab and Relatlimab-rmbw (Opdualag) (PDF) |
CP.PHAR.588 |
September 1, 2024 |
No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF) |
HIM.PA.33 |
January 1, 2025 |
Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF) |
CP.PHAR.684 |
January 1, 2025 |
Non-Calcium Phosphate Binders (Auryxia, Fosrenol, Renagel, Renvela, Velphoro) (PDF) |
CP.PMN.04 |
January 1, 2025 |
Non-Formulary and Formulary Contraceptives (PDF) |
HIM.PA.100 |
January 1, 2025 |
Non-Formulary Test Strips (PDF) |
HIM.PA.34 |
January 1, 2025 |
Nusinersen (Spinraza) (PDF) |
CP.PHAR.327 |
May 1, 2024 |
Obeticholic acid (Ocaliva) (PDF) |
CP.PHAR.287 |
January 1, 2025 |
Obinutuzumab (Gazyva) (PDF) |
CP.PHAR.305 |
January 1, 2025 |
Ocrelizumab (Ocrevus) (PDF) |
CP.PHAR.335 |
January 1, 2025 |
Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF) |
CP.PHAR.40 |
September 1, 2024 |
Odevixibat (Bylvay) (PDF) |
CP.PHAR.528 |
January 1, 2025 |
Ofatumumab (Arzerra, Kesimpta) (PDF) |
CP.PHAR.306 |
June 1, 2024 |
Off-Label Drug Use (PDF) |
HIM.PA.154 |
January 1, 2025 |
Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF) |
CP.PHAR.292 |
May 1, 2024 |
Olanzapine-samidorphan (Lybalvi) (PDF) |
CP.PMN.265 |
January 1, 2025 |
Olaparib (Lynparza) (PDF) |
CP.PHAR.360 |
January 1, 2025 |
Olipudase Alfa-rpcp (Xenpozyme) (PDF) |
CP.PHAR.586 |
September 1, 2024 |
Olutasidenib (Rezlidhia) (PDF) |
CP.PHAR.615 |
January 1, 2025 |
Omacetaxine (Synribo) (PDF) |
CP.PHAR.108 |
June 1, 2024 |
Omadacycline (Nuzyra) (PDF) |
CP.PMN.188 |
September 1, 2024 |
Omalizumab (Xolair) (PDF) |
CP.PCH.49 |
January 1, 2025 |
Omaveloxolone (RTA-408) (PDF) |
CP.PHAR.590 |
January 1, 2025 |
OnabotulinumtoxinA (Botox) (PDF) |
CP.PHAR.232 |
January 1, 2025 |
OnabotulinumtoxinA (Botox) (PDF) |
CP.PHAR.232 |
January 1, 2025 |
Onasemnogene Abeparvovec (Zolgensma) (PDF) |
CP.PHAR.421 |
September 1, 2024 |
Ophthalmic Corticosteroids (PDF) |
HIM.PA.03 |
January 1, 2025 |
Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF) |
CP.PHAR.536 |
January 1, 2025 |
Opicapone (Ongentys) (PDF) |
CP.PMN.245 |
January 1, 2025 |
Opioid Analgesics (PDF) |
HIM.PA.139 |
January 1, 2025 |
Osilodrostat (Isturisa) (PDF) |
CP.PHAR.487 |
January 1, 2025 |
Osimertinib (Tagrisso) (PDF) |
CP.PHAR.294 |
January 1, 2025 |
Ospemifene (Osphena) (PDF) |
CP.PMN.168 |
January 1, 2025 |
Overactive Bladder Agents (PDF) |
CP.PMN.198 |
January 1, 2025 |
Oxymetazoline (Rhofade) (PDF) |
CP.PMN.86 |
January 1, 2025 |
Ozanimod (Zeposia) (PDF) |
CP.PHAR.462 |
January 1, 2025 |
Ozenoxacin (Xepi) (PDF) |
CP.PMN.119 |
January 1, 2025 |
Paclitaxel, Protein-Bound (Abraxane) (PDF) |
CP.PHAR.176 |
January 1, 2025 |
Pacritinib (Vonjo) (PDF) |
CP.PHAR.583 |
January 1, 2025 |
Palbociclib (Ibrance) (PDF) |
HIM.PA.173 |
January 1, 2025 |
Paliperidone Long-Acting Injections (Invega Hafyera, Invega Sustenna, Invega Trinza) (PDF) |
CP.PHAR.291 |
May 1, 2024 |
Palivizumab (Synagis) (PDF) |
CP.PHAR.16 |
May 1, 2024 |
Palopegteriparatide (Yorvipath) (PDF) |
CP.PHAR.696 |
January 1, 2025 |
Palovarotene (PDF) |
CP.PHAR.548 |
January 1, 2025 |
Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep) (PDF) |
CP.PCH.44 |
March 1, 2025 |
Panitumumab (Vectibix) (PDF) |
CP.PHAR.321 |
Retire by March 1, 2025 |
Panitumumab (Vectibix) (PDF) |
CP.PHAR.321 |
March 1, 2025 |
Parathyroid Hormone (Natpara) (PDF) |
CP.PHAR.282 |
January 1, 2025 |
Paricalcitol Injection (Zemplar) (PDF) |
CP.PHAR.270 |
September 1, 2024 |
Pasireotide (Signifor, Signifor LAR) (PDF) |
CP.PHAR.332 |
January1, 2025 |
Patiromer (Veltassa) (PDF) |
CP.PMN.205 |
January 1, 2025 |
Patisiran (Onpattro) (PDF) |
CP.PHAR.395 |
July 1, 2024 |
Pazopanib (Votrient) (PDF) |
CP.PHAR.81 |
January 1, 2025 |
Peanut allergen powder (Palforzia) (PDF) |
CP.PMN.220 |
January 1, 2025 |
Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (PDF) |
CP.PHAR.353 |
Retire by March 1, 2025 |
Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (PDF) |
CP.PHAR.353 |
March 1, 2025 |
Pegcetacoplan (Empaveli, APL-2) (PDF) |
CP.PHAR.524 |
October 1, 2024 |
Pegfilgrastim/Biosimilars, Eflapegrastim, Efbemalenograstim (PDF) |
CP.PHAR.296 |
January 1, 2025 |
Peginterferon Alfa-2a (Pegasys) (PDF) |
CP.PHAR.89 |
January 1, 2025 |
Peginterferon beta-1a (Plegridy) (PDF) |
CP.PHAR.271 |
January 1, 2025 |
Pegloticase (Krystexxa) (PDF) |
CP.PHAR.115 |
May 1, 2024 |
Pegunigalsidase Alfa-iwxj (Elfabrio) (PDF) |
CP.PHAR.512 |
September 1, 2024 |
Pegvaliase-pqpz (Palynziq) (PDF) |
CP.PHAR.140 |
Retire by March 1, 2025 |
Pegvaliase-pqpz (Palynziq) (PDF) |
CP.PHAR.140 |
March 1, 2025 |
Pegvisomant (Somavert) (PDF) |
CP.PHAR.389 |
January 1, 2025 |
Pembrolizumab (Keytruda®) (PDF) |
CP.PHAR.322 |
January 1, 2025 |
Pemetrexed (Alimta, Pemfexy) (PDF) |
CP.PHAR.368 |
January 1, 2025 |
Pemigatinib (Pemazyre) (PDF) |
CP.PHAR.496 |
January 1, 2025 |
Penicillamine (Cuprimine) (PDF) |
CP.PCH.09 |
January 1, 2025 |
Perampanel (Fycompa) (PDF) |
CP.PMN.156 |
January 1, 2025 |
Perfluorohexyloctane (Miebo) (PDF) |
CP.PMN.290 |
January 1, 2025 |
Pertuzumab (Perjeta) (PDF) |
CP.PHAR.227 |
June 1, 2024 |
Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (PDF) |
CP.PHAR.501 |
September 1, 2024 |
Pexidartinib (Turalio)(PDF) |
CP.PHAR.436 |
January 1, 2025 |
Phendimetrazine (PDF) |
CP.PCH.47 |
January 1, 2025 |
Phentermine (Adipex-P, Lomaira) (PDF) |
CP.PCH.13 |
January 1, 2025 |
Pilocarpine (Vuity) (PDF) |
CP.PMN.270 |
January 1, 2025 |
Pimavanserin (Nuplazid) (PDF) |
CP.PMN.140 |
January 1, 2025 |
Pirfenidone (Esbriet) (PDF) |
CP.PHAR.286 |
January 1, 2025 |
Pirtobrutinib (Jaypirca) (PDF) |
CP.PHAR.620 |
January 1, 2025 |
Pitolisant (Wakix) (PDF) |
CP.PMN.221 |
January 1, 2025 |
Plasminogen, human-tvmh (Ryplazim) (PDF) |
CP.PHAR.513 |
January1, 2025 |
Plecanatide (Trulance) (PDF) |
CP.PMN.87 |
January 1, 2025 |
Plerixafor (Mozobil) (PDF) |
CP.PHAR.323 |
October 1, 2024 |
Polatuzumab Vedotin-piiq (Polivy) (PDF) |
CP.PHAR.433 |
September 1, 2024 |
Pomalidomide (Pomalyst) (PDF) |
CP.PHAR.116 |
January 1, 2025 |
Ponatinib (Iclusig) (PDF) |
CP.PHAR.112 |
January 1, 2025 |
Ponesimod (Ponvory) (PDF) |
CP.PHAR.537 |
January 1, 2025 |
Potassium (Klor-Con) (PDF) |
HIM.PA.143 |
January 1, 2025 |
Pozelimab-bbfg (Veopoz) (PDF) |
CP.PHAR.626 |
June 1, 2024 |
Pralatrexate (Folotyn) (PDF) |
CP.PHAR.313 |
Retire by March 1, 2025 |
Pralatrexate (Folotyn) (PDF) |
CP.PHAR.313 |
March 1, 2025 |
Pramlintide (Symlin) (PDF) |
CP.PMN.129 |
January 1, 2025 |
Prasterone (Intrarosa) (PDF) |
CP.PMN.99 |
January 1, 2025 |
Pregabalin (Lyrica) (PDF) |
CP.PMN.33 |
January 1, 2025 |
Pretomanid (PDF) |
CP.PMN.222 |
January 1, 2025 |
Progesterone (Crinone, Endometrin, Milprosa) (PDF) |
CP.PMN.243 |
January 1, 2025 |
Propranolol (Hemangeol) (PDF) |
CP.PCH.51 |
January 1, 2025 |
Protein C Concentrate, Human (Ceprotin) (PDF) |
CP.PHAR.330 |
May 1, 2024 |
Prucalopride (Motegrity) (PDF) |
HIM.PA.159 |
January 1, 2025 |
Pyrimethamine (Daraprim®) (PDF) |
CP.PMN.44 |
January 1, 2025 |
Quantity Limit Override and Dose Optimization (PDF) |
CP.PMN.59 |
January 1, 2025 |
Quetiapine ER (Seroquel XR) (PDF) |
CP.PMN.64 |
January 1, 2025 |
Quizartinib (Vanflyta) (PDF) |
CP.PHAR.646 |
January 1, 2025 |
Ramucirumab (Cyramza) (PDF) |
CP.PHAR.119 |
May 1, 2024 |
Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) (PDF) |
CP.PHAR.186 |
January 1, 2025 |
Rasagiline (Azilect®) (PDF) |
HIM.PA.89 |
January 1, 2025 |
Ravulizumab-cwvz (Ultomiris) (PDF) |
CP.PHAR.415 |
October 1, 2024 |
Regorafenib (Stivarga) (PDF) |
CP.PHAR.107 |
January 1, 2025 |
Relugolix (Orgovyx) (PDF) |
CP.PHAR.529 |
January 1, 2025 |
Remetirom (Rezdiffra) (PDF) |
CP.PHAR.647 |
January 1, 2025 |
Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (PDF) |
HIM.PA.168 |
May 1, 2024 |
Repotrectinib (Augtyro) (PDF) |
CP.PHAR.667 |
January 1, 2025 |
Reslizumab (Cinqair) (PDF) |
CP.PHAR.223 |
May 1, 2024 |
Respiratory syncytial virus vaccine (Abrysvo) (PDF) |
CP.PHAR.658 |
January 1, 2025 |
Retifanlimab-dlwr (Zynyz) (PDF) |
CP.PHAR.629 |
July 1, 2024 |
Ribavirin (Copegus, Moderiba, Rebetol, Ribasphere) (PDF) |
CP.PHAR.141 |
January 1, 2025 |
Ribociclib (Kisqali, Kisqali Femara) (PDF) |
CP.PHAR.334 |
March 1, 2025 |
Rifabutin (Mycobutin) (PDF) |
CP.PMN.223 |
January 1, 2025 |
Rifamycin (Aemcolo) (PDF) |
CP.PMN.196 |
January 1, 2025 |
Rifaximin (Xifaxan®) (PDF) |
CP.PMN.47 |
January 1, 2025 |
Rilonacept (Arcalyst) (PDF) |
CP.PHAR.266 |
July 1, 2024 |
RimabotulinumtoxinB (Myobloc) (PDF) |
CP.PHAR.233 |
June 1, 2024 |
Rimegepant (Nurtec ODT) (PDF) |
CP.PHAR.490 |
January 1, 2025 |
Riociguat (Adempas®) (PDF) |
CP.PHAR.195 |
January 1, 2025 |
Ripretinib (Qinlock) (PDF) |
CP.PHAR.502 |
January 1, 2025 |
Risdiplam (Evrysdi) (PDF) |
CP.PHAR.477 |
May 1, 2024 |
Risedronate (Actonel, Atelvia) (PDF) |
CP.PMN.100 |
January 1, 2025 |
Risperidone Long-Acting Injection (Perseris, Risperdal Consta, Rykindo, Uzedy) (PDF) |
CP.PHAR.293 |
May 1, 2024 |
Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (PDF) |
CP.PHAR.260 |
August 1, 2024 |
Roflumilast (Daliresp, Zoryve) (PDF) |
CP.PMN.46 |
January 1, 2025 |
Rolapitant (Varubi) (PDF) |
CP.PMN.102 |
January 1, 2025 |
Romidepsin (Istodax) (PDF) |
CP.PHAR.314 |
January1, 2025 |
Romiplostim (Nplate) (PDF) |
CP.PHAR.179 |
January 1, 2025 |
Romosozumab-aqqg (Evenity) (PDF) |
CP.PHAR.428 |
January 1, 2025 |
Ropeginterferon Alfa-2b-njft (BESREMi) (PDF) |
CP.PHAR.570 |
July 1, 2024 |
Rozanolixizumab-noli (Rystiggo) (PDF) |
CP.PHAR.648 |
Retire by March 1, 2025 |
Rozanolixizumab-noli (Rystiggo) (PDF) |
CP.PHAR.648 |
March 1, 2025 |
Rucaparib (Rubraca®) (PDF) |
CP.PHAR.350 |
January 1, 2025 |
Rufinamide (Banzel) (PDF) |
CP.PMN.157 |
January 1, 2025 |
Ruxolitinib (Jakafi) (PDF) |
CP.PHAR.98 |
January 1, 2025 |
Sacituzumab Govitecan-hziy (Trodelvy) (PDF) |
CP.PHAR.475 |
June 1, 2024 |
Sacubitril/Valsartan (Entresto) (PDF) |
CP.PCH.52 |
January 1, 2025 |
Safinamide (Xadago) (PDF) |
CP.PMN.113 |
January 1, 2025 |
Sapropterin (Kuvan) (PDF) |
CP.PHAR.43 |
January 1, 2025 |
Sarecycline (Seysara) (PDF) |
CP.PMN.189 |
January 1, 2025 |
Sargramostim (Leukine) (PDF) |
CP.PHAR.295 |
October 1, 2024 |
Satralizumab-mwge (Enspryng) (PDF) |
CP.PHAR.463 |
October 1, 2024 |
Sebelipase Alfa (Kanuma) (PDF) |
CP.PHAR.159 |
June 1, 2024 |
Secnidazole (Solosec) (PDF) |
CP.PMN.103 |
January 1, 2025 |
Seladelpar (Livdelzi) (PDF) |
CP.PHAR.698 |
January 1, 2025 |
Selexipag (Uptravi®) (PDF) |
CP.PHAR.196 |
January 1, 2025 |
Selinexor (Xpovio) (PDF) |
CP.PHAR.431 |
January 1, 2025 |
Selpercatinib (Retevmo) (PDF) |
CP.PHAR.478 |
January 1, 2025 |
Selumetinib (Koselugo) (PDF) |
CP.PHAR.464 |
January 1, 2025 |
Semaglutide (Wegovy) (PDF) |
CP.PMN.295 |
January 1, 2025 |
Sepsis Diagnosis (PDF) |
CC.PP.073 |
November 1, 2024 |
Setmelanotide (Imcivree) (PDF) |
CP.PHAR.491 |
January 1, 2025 |
Short ragweed pollen allergen extract (Ragwitek) (PDF) |
CP.PMN.83 |
January 1, 2025 |
Sildenafil (Revatio®) (PDF) |
CP.PHAR.197 |
January 1, 2025 |
Sildenafil (Viagra) (PDF) |
CP.PCH.07 |
January 1, 2025 |
Siltuximab (Sylvant) (PDF) |
CP.PHAR.329 |
May 1, 2024 |
Siponimod (Mayzent) (PDF) |
CP.PHAR.427 |
January 1, 2025 |
Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (PDF) |
CP.PHAR.574 |
May 1, 2024 |
Sodium Oxybate (Xyrem, Lumryz) and Calcium Magnesium Potassium Sodium Oxybate (Xywav) (PDF) |
CP.PMN.42 |
January 1, 2025 |
Sodium Phenylbutyrate (Buphenyl) (PDF) |
CP.PHAR.208 |
January 1, 2025 |
Sodium Phenylbutyrate-Taurursodiol (Relyvrio) 10.06.22.docx |
CP.PHAR.584 |
January 1, 2025 |
Sodium thiosulfate (Pedmark) (PDF) |
CP.PHAR.610 |
June 1, 2024 |
Sodium Zirconium Cyclosilicate (Lokelma) (PDF) |
CP.PMN.163 |
January 1, 2025 |
Sodium-Glucose Co-Transporter 2 Inhibitors (PDF) |
HIM.PA.91 |
January 1, 2025 |
Sofosbuvir (Sovaldi) (PDF) |
HIM.PA.SP2 |
January 1, 2025 |
Sofosbuvir-Vepatasvir-Voxilaprevir (Vosevi) (PDF) |
HIM.PA.SP63 |
January 1, 2025 |
Solriamfetol (Sunosi) (PDF) |
CP.PMN.209 |
January 1, 2025 |
Sonidegib (Odomzo) (PDF) |
CP.PHAR.272 |
January 1, 2025 |
Sorafenib (Nexavar) (PDF) |
CP.PHAR.69 |
January 1, 2025 |
Sotatercept (ACE-011) (PDF) |
CP.PHAR.657 |
January 1, 2025 |
Sotorasib (Lumakras) (PDF) |
CP.PHAR.549 |
January 1, 2025 |
Sparsentan (Filspari) (PDF) |
CP.PHAR.631 |
January 1, 2025 |
Spesolimab-sbzo (Spevigo) (PDF) |
CP.PHAR.606 |
August 1, 2024 |
Spinosad (Natroba) (PDF) |
HIM.PA.134 |
January 1, 2025 |
Step Therapy Criteria (PDF) |
HIM.PA.109 |
January 1, 2025 |
Stiripentol (Diacomit) (PDF) |
CP.PMN.184 |
January 1, 2025 |
Sunitinib (Sutent) (PDF) |
CP.PHAR.73 |
January 1, 2025 |
Sutimlimab-jome (Enjaymo) (PDF) |
CP.PHAR.503 |
June 1, 2024 |
Suvorexant (Belsomra®) (PDF) |
CP.PMN.109 |
January 1, 2025 |
Tadalafil (Adcirca®) (PDF) |
CP.PHAR.198 |
January 1, 2025 |
Tadalafil BHP - ED (Cialis) (PDF) |
CP.PMN.132 |
January 1, 2025 |
Tafamidis (Vyndaqel, Vyndamax) (PDF) |
CP.PHAR.432 |
January 1, 2025 |
Tafasitamab-cxix (Monjuvi) (PDF) |
CP.PHAR.508 |
Retire by March 1, 2024 |
Tafasitamab-cxix (Monjuvi) (PDF) |
CP.PHAR.508 |
March 1, 2024 |
Talazoparib (Talzenna)(PDF) |
CP.PHAR.409 |
January 1, 2025 |
Taliglucerase Alfa (Elelyso) (PDF) |
CP.PHAR.157 |
June 1, 2024 |
Talimogene laherepvec (Imlygic) (PDF) |
CP.PHAR.542 |
September 1, 2024 |
Talquetamab-tgvs (Talvey) (PDF) |
CP.PHAR.649 |
Retire by March 1, 2025 |
Talquetamab-tgvs (Talvey) (PDF) |
CP.PHAR.649 |
March 1, 2025 |
Tapinarof (Vtama) (PDF) |
CP.PMN.283 |
January 1, 2025 |
Tarlatamab-dlle (Imdelltra) (PDF) |
CP.PHAR.685 |
January 1, 2025 |
Tasimelteon (Hetlioz) (PDF) |
CP.PMN.104 |
January 1, 2025 |
Tavaborole (Kerydin®) (PDF) |
CP.PMN.105 |
January 1, 2025 |
Tazarotene (Arazlo, Fabior, Tazorac) (PDF) |
CP.PMN.244 |
January 1, 2025 |
Tazemetostat (PDF) |
CP.PHAR.452 |
January 1, 2025 |
Tebentafusp-tebn (Kimmtrak) (PDF) |
CP.PHAR.575 |
June 1, 2024 |
Teclistamab-cqyv (Tecvayli) (PDF) |
CP.PHAR.611 |
May 1, 2024 |
Tedizolid (Sivextro) (PDF) |
CP.PMN.62 |
September 1, 2024 |
Teduglutide (Gattex) (PDF) |
CP.PHAR.114 |
January 1, 2025 |
Telotristat ethyl (Xermelo) (PDF) |
CP.PHAR.337 |
January 1, 2025 |
Temozolomide (Temodar) (PDF) |
CP.PHAR.77 |
May 1, 2024 |
Temsirolimus (Torisel) (PDF) |
CP.PHAR.324 |
January1, 2025 |
Tenapanor (Ibsrela, Xphozah) (PDF) |
HIM.PA.174 |
March 1, 2025 |
Tenofovir Alafenamide Fumarate (Vemlidy) (PDF) |
CP.PMN.268 |
January 1, 2025 |
Teplizumab-mzwv (Tzield) (PDF) |
CP.PHAR.492 |
May 1, 2024 |
Tepotinib (Tepmetko) (PDF) |
CP.PHAR.530 |
January 1, 2025 |
Teprotumumab (Tepezza) (PDF) |
CP.PHAR.465 |
May 1, 2024 |
Teriflunomide (Aubagio) (PDF) |
CP.PCH.40 |
January 1, 2025 |
Teriparatide (Forteo®) (PDF) |
CP.PHAR.188 |
January 1, 2025 |
Tesamorelin (Egrifta) (PDF) |
CP.PHAR.109 |
January 1, 2025 |
Testosterone (Androderm) (PDF) |
HIM.PA.87 |
January 1, 2025 |
Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF) |
CP.PHAR.354 |
January1, 2025 |
Tetrabenazine (Xenazine) (PDF) |
CP.PHAR.92 |
January 1, 2025 |
Tezacaftor-Ivacaftor (Symdeko) (PDF) |
CP.PHAR.377 |
January 1, 2025 |
Tezepelumab-ekko (Tezspire) (PDF) |
CP.PHAR.576 |
May 1, 2024 |
Thalidomide (Thalomid) (PDF) |
CP.PHAR.78 |
January 1, 2025 |
Thioguanine (Tabloid) (PDF) |
CP.PHAR.437 |
January 1, 2025 |
Thyrotropin alfa (Thyrogen) (PDF) |
CP.PHAR.95 |
September 1, 2024 |
Timothy grass pollen allergen extract (Grastek®) (PDF) |
CP.PMN.84 |
January 1, 2025 |
Tiopronin Delayed-Release (Thiola EC) (PDF) |
CP.PCH.50 |
January 1, 2025 |
Tisagenlecleucel (Kymriah) (PDF) |
CP.PHAR.361 |
May 1, 2024 |
Tislelizumab-jsgr (Tevimbra) (PDF) |
CP.PHAR.687 |
November 1, 2024 |
Tisotumab Vedotin-tftv (Tivdak) (PDF) |
CP.PHAR.561 |
Retire by March 1, 2025 |
Tisotumab Vedotin-tftv (Tivdak) (PDF) |
CP.PHAR.561 |
March 1, 2025 |
Tivozanib (Fotivda) (PDF) |
CP.PHAR.538 |
January 1, 2025 |
Tobramycin (PDF) |
CP.PHAR.211 |
January 1, 2025 |
Tofersen (Qalsody) (PDF) |
CP.PHAR.591 |
January1, 2025 |
Tolvaptan (Jynarque) (PDF) |
CP.PHAR.27 |
January 1, 2025 |
Topical Acne Treatment (PDF) |
HIM.PA.71 |
January 1, 2025 |
Topical Immunomodulators (PDF) |
CP.PMN.107 |
January 1, 2025 |
Topiramate ER (Qudexy XR, Trokendi XR (PDF) |
CP.PMN.281 |
January 1, 2025 |
Topotecan (Hycamtin) (PDF) |
CP.PHAR.64 |
July 1, 2024 |
Toripalimab (Loqtorzi) (PDF) |
CP.PHAR.668 |
September 1, 2024 |
Tovorafenib (Ojemda) (PDF) |
CP.PHAR.686 |
January 1, 2025 |
Trabectedin (Yondelis) (PDF) |
CP.PHAR.204 |
May 1, 2024 |
Tralokinumab-ldrm (Adbry) (PDF) |
CP.PHAR.577 |
January 1, 2025 |
Trametinib (Mekinist) (PDF) |
CP.PHAR.240 |
January 1, 2025 |
Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (PDF) |
CP.PHAR.228 |
January 1, 2025 |
Travoprost (iDose TR) (PDF) |
CP.PHAR.672 |
August 1, 2024 |
Tremelimumab-actl (Imjudo) (PDF) |
CP.PHAR.612 |
December 1, 2024 |
Treprostinil (Orenitram®, Remodulin®, Tyvaso®) (PDF) |
CP.PHAR.199 |
January 1, 2025 |
Triamcinolone ER Injection (Zilretta) (PDF) |
CP.PHAR.371 |
January 1, 2025 |
Triclabendazole (Egaten) (PDF) |
CP.PMN.207 |
January 1, 2025 |
Trientine (Syprine) (PDF) |
CP.PHAR.438 |
January 1, 2025 |
Trifarotene (Aklief) (PDF) |
CP.PMN.225 |
January 1, 2025 |
Trifluridine/Tipiracil (Lonsurf) (PDF) |
CP.PHAR.383 |
January 1, 2025 |
Triheptanoin (Dojolvi) (PDF) |
CP.PHAR.509 |
January 1, 2025 |
Triptorelin Pamoate (Trelstar, Triptodur) (PDF) |
CP.PHAR.175 |
January 1, 2025 |
Trofinetide (Daybue) (PDF) |
CP.PHAR.600 |
January 1, 2025 |
Tucatinib (Tukysa) (PDF) |
CP.PHAR.497 |
January 1, 2025 |
Ublituximab-xiiy (Briumvi) (PDF) |
CP.PHAR.621 |
June 1, 2024 |
Ulcer Therapy Combinations (Omeclamox Pak, Pylera, Talicia)(PDF) |
CP.PMN.277 |
January 1, 2025 |
Umbralisib (Ukoniq) (PDF) |
CP.PHAR.531 |
January 1, 2025 |
Uridine acetate (Vistogard) (PDF) |
HIM.PA.SP55 |
January 1, 2025 |
Vadadustat (Vafseo) (PDF) |
CP.PHAR.677 |
January 1, 2025 |
Valbenazine (Ingrezza) (PDF) |
CP.PCH.48 |
January 1, 2025 |
valganciclovir (Valcyte) (PDF) |
CP.PCH.06 |
January 1, 2025 |
Valoctocogene Roxaparvovec-rvox (Roctavian) (PDF) |
CP.PHAR.466 |
May 1, 2024 |
Valrubicin (Valstar) (PDF) |
CP.PHAR.439 |
Retire by March 1, 2025 |
Valrubicin (Valstar) (PDF) |
CP.PHAR.439 |
March 1, 2025 |
Vamorolone (Agamree) (PDF) |
CP.PHAR.659 |
January 1, 2025 |
Vandetanib (Caprelsa®) (PDF) |
CP.PHAR.80 |
January 1, 2025 |
Varenicline (Tyrvaya) (PDF) |
CP.PMN.273 |
January 1, 2025 |
Velaglucerase Alfa (VPRIV) (PDF) |
CP.PHAR.163 |
June 1, 2024 |
Velmanase Alfa-tycv (Lamzede) (PDF) |
CP.PHAR.601 |
June 1, 2024 |
Velpatasvir (Epclusa) (PDF) |
HIM.PA.SP1 |
January 1, 2025 |
Vemurafenib (Zelboraf®) (PDF) |
CP.PHAR.91 |
January 1, 2025 |
Venetoclax (Venclexta) (PDF) |
CP.PHAR.129 |
January 1, 2025 |
Verteporfin (Visudyne) (PDF) |
CP.PHAR.187 |
May 1, 2024 |
Vestronidase Alfa-vjbk (Mepsevii) (PDF) |
CP.PHAR.374 |
July 1, 2024 |
Vigabatrin (Sabril) (PDF) |
CP.PHAR.169 |
January 1, 2025 |
Viloxazine (Qelbree) (PDF) |
CP.PMN.264 |
January 1, 2025 |
Viltolarsen (Viltepso) (PDF) |
CP.PHAR.484 |
May 1, 2024 |
Vismodegib (Erivedge) (PDF) |
CP.PHAR.273 |
January 1, 2025 |
Voclosporin (Lupkynis) (PDF) |
CP.PHAR.504 |
January 1, 2025 |
Vorapaxar (Zontivity) (PDF) |
HIM.PA.146 |
January 1, 2025 |
Vorasidenib (Voranigo) (PDF) |
CP.PHAR.699 |
January 1, 2025 |
Voretigene Neparvovec-rzyl (Luxturna) (PDF) |
CP.PHAR.372 |
May 1, 2024 |
Vorinostat (Zolinza) (PDF) |
CP.PHAR.83 |
January 1, 2025 |
Vortioxetine (Trintellix®) (PDF) |
CP.PMN.65 |
January 1, 2025 |
Voxelotor (Oxbryta) (PDF) |
CP.PHAR.451 |
January 1, 2025 |
Vutrisiran (Amvuttra) |
CP.PHAR.550 |
January 1, 2025 |
Zanubrutinib (Brukinsa) (PDF) |
CP.PHAR.467 |
January 1, 2025 |
Zavegepant (Zavzpret) (PDF) |
CP.PHAR.630 |
Retire by March 1, 2025 |
Zavegepant (Zavzpret) (PDF) |
CP.PHAR.630 |
March 1, 2025 |
Zilucoplan (RA101495) (PDF) |
CP.PHAR.616 |
January 1, 2025 |
Ziv-aflibercept (Zaltrap) (PDF) |
CP.PHAR.325 |
January 1, 2025 |
Zolbetuximab-clzb (Vyloy) (PDF) |
CP.PHAR.705 |
January 1, 2025 |
Zoledronic Acid (Reclast) (PDF) |
CP.PHAR.59 |
May 1, 2024 |
Zuranolone (Zurzuvae) (PDF) |
CP.PHAR.650 |
January 1, 2025 |